Advertisement.

PRTA Projected Dividend Yield

Ord/Prothena Corp Plc ( NASDAQ : PRTA )

Prothena is a biotechnology company engaged in the protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. Co. is developing a pipeline of therapeutic candidates for a number of indications and targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be utilized. Co.'s wholly-owned programs include birtamimab for the treatment of AL amyloidosis, a portfolio of programs for the treatment of Alzheimer's disease including PRX012 that targets Amyloid beta and a dual Amyloid beta-Tau vaccine.

20 YEAR PERFORMANCE RESULTS

PRTA Dividend History Detail
PRTA Dividend News
PRTA Competitors News

# of Shares: 0

Closing Price: 12.79

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000